Salesforce posts an earnings beat — but stock drop shows investors are still wary of AI adoption

Salesforce reported a Q2 revenue beat of $10.24 billion and an 11% year-over-year increase in current remaining performance obligations (cRPO) to $29.4 billion, alongside an acceleration in revenue growth. However, the stock dropped 5% in after-hours trading as the company's Q3 revenue outlook came in slightly below analyst expectations, fueling investor wariness regarding AI's potential disruption to its traditional software model and the perceived need for more significant top-line acceleration and clear AI monetization strategies.

Analysis

Salesforce, Inc. reported a solid fiscal second quarter, yet faced a negative market reaction, highlighting persistent investor skepticism regarding its AI transition. The company surpassed analyst expectations with Q2 revenue of $10.24 billion, a 10% year-over-year increase, and current remaining performance obligations (cRPO) of $29.4 billion, up 11% YoY. Notably, revenue growth accelerated from 8% in the prior quarter, a specific metric analysts were monitoring. However, this progress was overshadowed by a slightly soft outlook. The fiscal third-quarter revenue guidance of $10.24 billion to $10.29 billion fell just shy of the $10.29 billion Wall Street consensus at its midpoint. This marginal miss was enough to trigger a 5% drop in after-hours trading, reflecting a broader investor wariness about AI disrupting traditional software models. Despite raising the low end of its full-year revenue guidance, the market's reaction indicates that investors require more definitive proof of AI monetization and more significant top-line acceleration to overcome the competitive threat narrative, which has contributed to a 22% stock decline year-to-date.

Key Decisions for Investors

• Given the acceleration in revenue growth and the 11% increase in cRPO, investors with a long-term thesis on the company's AI strategy may consider the post-earnings share price dip an opportunity, as fundamental execution remains strong.
• Investors should exercise caution, as the market's negative reaction to a minor guidance miss signals a high bar for performance and a demand for concrete evidence of AI monetization, which has not yet been detailed.
• Monitor future earnings reports for sustained revenue acceleration and cRPO growth above 10%, as these are the key proof points the market is demanding to validate the company's transition and refute the bear argument on AI disruption.